Loading page…

Report overview

The report describes Pharmstandard's 2013 performance, including consolidated revenue of RUB55,907,597 thousand and a year-end workforce of 6,981 full-time employees. It also records the completed spin-off of the Branded OTC business into OTCPharm, a major organizational change during the year. The report further presents the Group's pharmaceutical portfolio, manufacturing operations, governance structure, and audited consolidated financial statements.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2013
Period: 1 January 2013 – 31 December 2013
Publication date: 25 April 2014
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

Assurance

Level
Standard
Scope
Statement included

ESG & Materiality

ESG data

Indicators available in this report:

Employees

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown for your project.

Explore our services